Reversibility of malignant hypertension
Cruz, J.
Revista do Hospital das Clinicas 26(1): 1-4
1971
ISSN/ISBN: 0041-8781 PMID: 5553899 Document Number: 40325
Document emailed within 1 workday
Related Documents
Scott, V.; De Wolf, A.; Kang, Y.; Martin, M.; Selby, R.; Fung, J.; Doyle, H.; Ziady, G.; Paradis, I.; Miro, A. 1993: Reversibility of pulmonary hypertension after liver transplantation: a case report Transplantation Proceedings 25(2): 1789-1790Ressil, J.; Urbanová, D.; Widimský, J.; Ostádal, B.; Pelouch, V.; Procházka, J. 1975: Reversibility of chronic pulmonary hypertension. Experimental study in the rat author's transl Casopis Lekaru Ceskych 114(14): 435-438
Swierad, M.; Zakliczyński, M.ł; Maruszewski, M.; Zebik, T.; Honisz, G.; Chodór, P.; Wojarski, J.; Nadziakiewicz, P.ł; Kucewicz, E.; Przybylski, R.; Gasior, M.; Poloński, L.; Kalarus, Z.; Zembala, M. 2009: Reversibility of pulmonary hypertension assessment as an expected standard of diagnosis and prognosis on cardiology ward in Poland Kardiologia Polska 67(1): 106-109
Iavorkovskiĭ, L.I.; Nikul'shin, S.V.; Iavorkovskiĭ, L.L.; Klutse, G.K.; Skrodele, M.Ia.; Udris, L.Iu. 1991: Reversibility of the development of malignant lymphoma with 7-years of leukemization, associated with the development of chronic myeloleukemia Gematologiia i Transfuziologiia 36(10): 35-37
Kishimoto, M. 1984: Malignant hypertension Nihon Rinsho. Japanese Journal of Clinical Medicine 42(2): 460-464
Hano, T.; Nishio, I. 2001: Malignant hypertension Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 8): 677-682
Nomura, G. 1970: Malignant hypertension Nihon Rinsho. Japanese Journal of Clinical Medicine 28(Suppl): 1100-1101
Krämer, B.K.; Riegger, G.A. 1995: Role of endothelin in malignant hypertension Clinical Nephrology 44(2): 136-137
Radó, J.; Szücs, L. 1983: Hyponatremia in malignant renovascular hypertension Orvosi Hetilap 124(43): 2621-2628
Schley, G.; Kapp, A.; Günnewig, H.; Bock, K.D. 1979: Follow-up in treated malignant hypertension Die Medizinische Welt 30(50): 1875-1884
Baglin, A.; Weiss, Y.; Safar, M.; Milliez, P. 1973: Primary hyperaldosteronism with malignant hypertension La Nouvelle Presse Medicale 2(5): 295-297
Takagi, N.; Ishii, M. 1992: Hemodialysis therapy of malignant hypertension Nihon Rinsho. Japanese Journal of Clinical Medicine 50 Suppl: 164-170
Kuzmanić, D.; Marinković, M.; Winter-Fudurić, I.; Ficović, P.; Roncević, T. 1985: Malignant arterial hypertension. A review of 88 patients Przeglad Lekarski 42(3): 335-338
Rosbotham, J.; Ritter, J.M.; Watson, J.P. 1992: Hallucinations as a presenting feature in malignant hypertension British Journal of Clinical Practice 46(2): 140
Mazza, A.; Della Rocca, F.; Mormino, P.; Pessina, A.C. 1996: Hypertension secondary to multiple malignant paragangliomas Giornale Italiano di Cardiologia 26(8): 891-897
Ribet, M.; Quandalle, P.; Lekieffre, J.; Menez, J.; Hassoun, A.; Houcke, M.; Lelievre, G.; Gosselin, B. 1971: Sympatho-adrenalectomy in malignant essential hypertension La Presse Medicale 79(1): 14
Herbland, A.; Lasserre, R.; Minifie, C.; Lemetayer, P.; Clementy, J.; Gosse, P. 2004: Malignant hypertension. Case series of 42 patients Archives des Maladies du Coeur et des Vaisseaux 97(4): 299-304
Zeitler, E. 1975: Radiological diagnosis in malignant hypertension and microangiopathies Die Medizinische Welt 26(10): 427-432
Nakayama, M.; Hara, M.; Kuwahara, K.; Miura, H.; Tazoe, N.; Ito, J. 1985: A case of IgA nephropathy associated with malignant hypertension and cerebral hemorrhage Nihon Jinzo Gakkai Shi 27(6): 859-863
Salyer, W.R.; Hutchins, G.M. 1974: Glomoid lesions in systemic arteries in malignant hypertension Archives of Pathology 97(2): 104-106